(1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (ii) has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernhardt, G; Schlemmer, R; Schönenberger, H; Spruss, T | 2 |
2 other study(ies) available for (1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine)dichloroplatinum (ii) and Breast Neoplasms
Article | Year |
---|---|
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)et
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cyclosporine; Female; Humans; Immunity; Immunologic Factors; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Organoplatinum Compounds; T-Lymphocytes; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |
Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Division; Female; Humans; Immunity, Cellular; Immunologic Factors; Mice; Mice, Inbred Strains; Organoplatinum Compounds; Phagocytes; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |